Internal Medicine · New Brunswick, NJ
NPI
1962963652
Since 2019
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
125 Paterson St
New Brunswick, NJ, 08901
Phone (732) 235-8887
Groups this clinician bills Medicare through
Medicare paid, 2024
$32K
804 services
Medicare patients, 2024
175
Average age 74
Drug cost, 2024
$340K
2,265 prescriptions
Company payments, 2025
$962
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kun Pan was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 312 times for 148 patients. In total Kun Pan billed 804 services in 21 codes, and Medicare paid $32K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-11-16.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 312 | 148 | $11.68 | $3,644 |
| 99214 Office E&M - Established | Office | 252 | 130 | $56.79 | $14K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 71 | 71 | $55.57 | $3,946 |
| 99213 Office E&M - Established | Office | 62 | 50 | $50.10 | $3,106 |
| 99204 Office E&M - New | Office | 31 | 31 | $74.20 | $2,300 |
| G0008 Administration of influenza virus vaccine | Office | 20 | 20 | $35.50 | $710 |
| 90662 Vaccine Product | Office | 19 | 19 | $80.78 | $1,535 |
By year: 2022 $4,731 for 46 services; 2023 $43K for 509 services; 2024 $32K for 804 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kun Pan prescribed most often to Medicare patients was Atorvastatin Calcium, with 180 prescriptions and refills. In total Kun Pan wrote 2,265 Medicare prescriptions that cost $340K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 180 | 495 | 67 | $1,913 |
| Amlodipine Besylate Generic | 157 | 415 | 61 | $1,334 |
| Rosuvastatin Calcium Generic | 153 | 403 | 51 | $2,256 |
| Metoprolol Succinate Generic | 91 | 263 | 33 | $1,359 |
| Metformin Hcl Generic | 84 | 207 | 28 | $600 |
| Losartan Potassium Generic | 60 | 169 | 27 | $681 |
| Ozempic Semaglutide | 60 | 75 | 12 | $63K |
| Telmisartan Generic | 59 | 142 | 18 | $1,495 |
| Levothyroxine Sodium Generic | 56 | 153 | 21 | $884 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 43 | 49 | 19 | $1,453 |
| Hydrochlorothiazide Generic | 42 | 118 | 15 | $174 |
| Lisinopril Generic | 39 | 109 | 22 | $366 |
| Jardiance Empagliflozin | 36 | 67 | Under 11 | $38K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 35 | 39 | Under 11 | $24K |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 35 | 91 | 12 | $414 |
Brand drugs: 379 claims; generic drugs: 1,865 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kun Pan $962 ($962 in general payments such as food, travel and fees) from 14 companies. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $266.
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 10 | $266 |
| Pfizer Inc. PFE | 6 | $104 |
| Amgen Inc. AMGN | 6 | $94.83 |
| Novo Nordisk Inc NVO | 5 | $87.7 |
| Abbvie Inc. ABBV | 5 | $87.34 |
| Lilly USA, LLC LLY | 4 | $72.88 |
| Exact Sciences Corporation EXAS | 4 | $67.93 |
| Abbott Laboratories ABT | 2 | $49.26 |
| Genzyme Corporation SNY | 2 | $35.89 |
| Inspire Medical Systems, Inc. INSP | 1 | $23.13 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.